Decitabine

Decitabine (i.e., 5-aza-2′-deoxycytidine), sold under the brand name Dacogen among others, acts as a nucleic acid synthesis inhibitor. It is a medication for the treatment of myelodysplastic syndromes, a class of conditions where certain blood cells are dysfunctional, and for acute myeloid leukemia (AML). Chemically, it is a cytidine analog.

Decitabine
Clinical data
Trade namesDacogen, Demylocan
Other names5-aza-2'-deoxycytidine
AHFS/Drugs.comMonograph
MedlinePlusa608009
License data
Routes of
administration
Intravenous
ATC code
Legal status
Legal status
  • CA: ℞-only
  • US: ℞-only
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Protein binding<1%
Elimination half-life30 minutes
Identifiers
  • 4-Amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-1,3,5-triazin-2(1H)-one
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.017.355
Chemical and physical data
FormulaC8H12N4O4
Molar mass228.208 g·mol−1
3D model (JSmol)
SMILES
  • O=C1/N=C(\N=C/N1[C@@H]2O[C@@H]([C@@H](O)C2)CO)N
  • InChI=1S/C8H12N4O4/c9-7-10-3-12(8(15)11-7)6-1-4(14)5(2-13)16-6/h3-6,13-14H,1-2H2,(H2,9,11,15)/t4-,5+,6+/m0/s1 Y
  • Key:XAUDJQYHKZQPEU-KVQBGUIXSA-N Y
 NY (what is this?)  (verify)
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.